Clinical Trial Update: Luteal Phase FSH in the IVF Poor Responder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating luteal phase administration of follicle-stimulating hormone in poor responders undergoing IVF. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Follicle-stimulating hormone (FSH) (Follicle-stimulating hormone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Infertility | Phase 4 | Status: COMPLETED